(1.26%) 5 127.79 points
(1.18%) 38 676 points
(1.99%) 16 156 points
(0.26%) $78.31
(0.19%) $2.15
(0.42%) $2 318.40
(1.73%) $27.15
(-0.61%) $959.40
(0.03%) $0.929
(-0.03%) $10.87
(0.01%) $0.797
(0.00%) $91.45
Live Chart Being Loaded With Signals
Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe...
Stats | |
---|---|
Volumen de hoy | 0 |
Volumen promedio | 0 |
Capitalización de mercado | 0 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | 0 |
ATR14 | $0 (0.00%) |
Dynavax Technologies Correlación
10 Correlaciones Más Positivas |
---|
10 Correlaciones Más Negativas |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Dynavax Technologies Finanzas
Annual | 2020 |
Ingresos: | $46.55M |
Beneficio Bruto: | $32.64M (70.12 %) |
EPS: | $-0.750 |
FY | 2020 |
Ingresos: | $46.55M |
Beneficio Bruto: | $32.64M (70.12 %) |
EPS: | $-0.750 |
FY | 2019 |
Ingresos: | $35.22M |
Beneficio Bruto: | $15.83M (44.95 %) |
EPS: | $0 |
FY | 2018 |
Ingresos: | $8.20M |
Beneficio Bruto: | $-13.60M (-165.87 %) |
EPS: | $0 |
Financial Reports:
No articles found.
Dynavax Technologies
Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufactures and sells CpG 1018, the adjuvant used in HEPLISAV-B. Dynavax Technologies Corporation has a collaboration agreement with Valneva Scotland Limited; agreement with Serum Institute of India Pvt. Ltd.; and sublicense agreement with Merck, Sharp & Dohme Corp. The company was formerly known as Double Helix Corporation and changed its name to Dynavax Technologies Corporation in September 1996. Dynavax Technologies Corporation was incorporated in 1996 and is headquartered in Emeryville, California.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico